Who Paid My Doc Search
Menu
Product Program year 2019 Source: CMS Open Payments

Sutimlimab

Drug

Open in the dashboard

General payments

$10,517

20 payments

Research payments

$161,361

46 payments

Through program year 2019, $10,517 in general payments and $161,361 in research payments were reported against Sutimlimab.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $10,517 20
2019 Research $161,361 46

Breakdown

Who paid General payments · program year 2019
  1. Bioverativ Therapeutics Inc. $9,838 14 payments
  2. Genzyme Corporation $552 4 payments
  3. Sanofi-Aventis U.S. LLC $127 2 payments
Top recipients General payments · program year 2019
  1. Catherine Broome Hematology & Oncology · Washington, DC $9,718 92% · 12 payments
  2. Marianne Pinkston Family Medicine · San Antonio, TX $319 3% · 1 payment
  3. Julia Cunningham Hematology & Oncology · Washington, DC $120 1% · 2 payments
  4. Kleber Yotsumoto Fertrin Hematology · Seattle, WA $83 <1% · 1 payment
  5. Livia Hegerova Hematology & Oncology · Seattle, WA $78 <1% · 1 payment

The top 5 of 8 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Hematology & Oncology Internal Medicine $9,965 95% · 4 practitioners
  2. Family Medicine $319 3% · 1 practitioner
  3. Hematology Internal Medicine $83 <1% · 1 practitioner
  4. Internal Medicine $75 <1% · 1 practitioner
  5. Anatomic Pathology & Clinical Pathology Pathology $75 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2019
  1. District of Columbia $9,838 94% · 2 recipients
  2. Texas $319 3% · 1 recipient
  3. Washington $161 2% · 2 recipients
  4. California $75 <1% · 1 recipient
  5. Maryland $75 <1% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

20 general · 46 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record